Microbiome therapeutic offers durable protection against C. difficile recurrenceMay 28, 2021GastroenterologyInfectious Diseases
Racial and ethnic minorities underrepresented in pancreatic cancer clinical trialsMay 27, 2021GastroenterologyOncology
FDA restricts obeticholic acid (Ocaliva) over serious liver injury riskMay 26, 2021GastroenterologyHepatology
Pandemic colonoscopy restrictions may lead to worse CRC outcomesMay 26, 2021GastroenterologyCOVID-19 Updates
FDA OKs nivolumab after surgery for esophageal or GEJ cancer: Practice-changing use of immunotherapyMay 24, 2021GastroenterologyOncology
